Puma Biotechnology (PBYI) Other financing activities (2018 - 2022)

Puma Biotechnology (PBYI) reported Other financing activities of $69000.0 for Q4 2022, up 30.19% quarter-over-quarter from $53000.0 in Q3 2022.

Puma Biotechnology (PBYI) Other financing activities (2018 - 2022) Analysis & Trends

Puma Biotechnology has reported Other financing activities for 2 years, with the latest figure at $69000.0 in Q4 2022.

For the quarter ending Q4 2022, Other financing activities changed N/A year-over-year to $69000.0; the trailing twelve-month figure through Sep 2023 stood at $69000.0 (down 66.83% YoY), and the FY2022 full-year result was $277000.0, changed N/A from the prior year.
Other financing activities for Q4 2022 stood at $69000.0, up from $53000.0 in the prior quarter.
The five-year high for Other financing activities was $155000.0 in Q1 2022, with the low at $9000.0 in Q4 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Puma Biotechnology	384.39 Mn	282.84 Mn	34.39 Mn

Download Data